These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 35900152)
1. Reduced Cathepsin L expression and secretion into the extracellular milieu contribute to lung fibrosis in systemic sclerosis. Mouawad JE; Sharma S; Renaud L; Pilewski JM; Nadig SN; Feghali-Bostwick C Rheumatology (Oxford); 2023 Mar; 62(3):1306-1316. PubMed ID: 35900152 [TBL] [Abstract][Full Text] [Related]
2. Role of Extracellular Vesicles in the Propagation of Lung Fibrosis in Systemic Sclerosis. Mouawad JE; Sanderson M; Sharma S; Helke KL; Pilewski JM; Nadig SN; Feghali-Bostwick C Arthritis Rheumatol; 2023 Dec; 75(12):2228-2239. PubMed ID: 37390364 [TBL] [Abstract][Full Text] [Related]
3. A potential contribution of altered cathepsin L expression to the development of dermal fibrosis and vasculopathy in systemic sclerosis. Yamashita T; Asano Y; Taniguchi T; Nakamura K; Saigusa R; Takahashi T; Ichimura Y; Toyama T; Yoshizaki A; Miyagaki T; Sugaya M; Sato S Exp Dermatol; 2016 Apr; 25(4):287-92. PubMed ID: 26661692 [TBL] [Abstract][Full Text] [Related]
4. CD109, a TGF-β co-receptor, attenuates extracellular matrix production in scleroderma skin fibroblasts. Man XY; Finnson KW; Baron M; Philip A Arthritis Res Ther; 2012 Jun; 14(3):R144. PubMed ID: 22694813 [TBL] [Abstract][Full Text] [Related]
5. Increased expression of latent TGF-β-binding protein 4 affects the fibrotic process in scleroderma by TGF-β/SMAD signaling. Lu J; Liu Q; Wang L; Tu W; Chu H; Ding W; Jiang S; Ma Y; Shi X; Pu W; Zhou X; Jin L; Wang J; Wu W Lab Invest; 2017 May; 97(5):591-601. PubMed ID: 28263294 [TBL] [Abstract][Full Text] [Related]
6. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors. Kawaguchi Y; Takagi K; Hara M; Fukasawa C; Sugiura T; Nishimagi E; Harigai M; Kamatani N Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619 [TBL] [Abstract][Full Text] [Related]
7. Pro-fibrotic phenotype of human skin fibroblasts induced by periostin via modulating TGF-β signaling. Kanaoka M; Yamaguchi Y; Komitsu N; Feghali-Bostwick CA; Ogawa M; Arima K; Izuhara K; Aihara M J Dermatol Sci; 2018 May; 90(2):199-208. PubMed ID: 29433908 [TBL] [Abstract][Full Text] [Related]
8. Lysyl oxidase directly contributes to extracellular matrix production and fibrosis in systemic sclerosis. Nguyen XX; Nishimoto T; Takihara T; Mlakar L; Bradshaw AD; Feghali-Bostwick C Am J Physiol Lung Cell Mol Physiol; 2021 Jan; 320(1):L29-L40. PubMed ID: 33026236 [TBL] [Abstract][Full Text] [Related]
9. Overexpression of hepatocyte growth factor receptor in scleroderma dermal fibroblasts is caused by autocrine transforming growth factor β signaling. Kajihara I; Jinnin M; Makino T; Masuguchi S; Sakai K; Fukushima S; Maruo K; Inoue Y; Ihn H Biosci Trends; 2012 Jun; 6(3):136-42. PubMed ID: 22890162 [TBL] [Abstract][Full Text] [Related]
10. Localized expression of tenascin in systemic sclerosis-associated pulmonary fibrosis and its regulation by insulin-like growth factor binding protein 3. Brissett M; Veraldi KL; Pilewski JM; Medsger TA; Feghali-Bostwick CA Arthritis Rheum; 2012 Jan; 64(1):272-80. PubMed ID: 21898349 [TBL] [Abstract][Full Text] [Related]
11. Scleroderma fibroblasts suppress angiogenesis via TGF-β/caveolin-1 dependent secretion of pigment epithelium-derived factor. Liakouli V; Elies J; El-Sherbiny YM; Scarcia M; Grant G; Abignano G; Derrett-Smith EC; Esteves F; Cipriani P; Emery P; Denton CP; Giacomelli R; Mavria G; Del Galdo F Ann Rheum Dis; 2018 Mar; 77(3):431-440. PubMed ID: 29259049 [TBL] [Abstract][Full Text] [Related]
13. Decreased expression of caveolin 1 in patients with systemic sclerosis: crucial role in the pathogenesis of tissue fibrosis. Del Galdo F; Sotgia F; de Almeida CJ; Jasmin JF; Musick M; Lisanti MP; Jiménez SA Arthritis Rheum; 2008 Sep; 58(9):2854-65. PubMed ID: 18759267 [TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor-II is increased in systemic sclerosis-associated pulmonary fibrosis and contributes to the fibrotic process via Jun N-terminal kinase- and phosphatidylinositol-3 kinase-dependent pathways. Hsu E; Feghali-Bostwick CA Am J Pathol; 2008 Jun; 172(6):1580-90. PubMed ID: 18467708 [TBL] [Abstract][Full Text] [Related]
16. Vitamin D receptor regulates TGF-β signalling in systemic sclerosis. Zerr P; Vollath S; Palumbo-Zerr K; Tomcik M; Huang J; Distler A; Beyer C; Dees C; Gela K; Distler O; Schett G; Distler JH Ann Rheum Dis; 2015 Mar; 74(3):e20. PubMed ID: 24448349 [TBL] [Abstract][Full Text] [Related]
18. Role of endostatin in fibroproliferative disorders.-as a candidate for anti-fibrosis therapy-. Yamaguchi Y; Feghali-Bostwick CA Nihon Rinsho Meneki Gakkai Kaishi; 2013; 36(6):452-8. PubMed ID: 24390105 [TBL] [Abstract][Full Text] [Related]